CR11285A - Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihipropiridina y metodo para la prepacion de la misma - Google Patents

Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihipropiridina y metodo para la prepacion de la misma

Info

Publication number
CR11285A
CR11285A CR11285A CR11285A CR11285A CR 11285 A CR11285 A CR 11285A CR 11285 A CR11285 A CR 11285A CR 11285 A CR11285 A CR 11285A CR 11285 A CR11285 A CR 11285A
Authority
CR
Costa Rica
Prior art keywords
calcium channel
dihipropiridine
antigonist
type
preparation
Prior art date
Application number
CR11285A
Other languages
English (en)
Inventor
Evangelos Karavas
Efthimios Koutris
Ioanna Koutri
Eleni Stathaki
Original Assignee
Pharmathen Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39223083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CR11285(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmathen Sa filed Critical Pharmathen Sa
Publication of CR11285A publication Critical patent/CR11285A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente invencion se relaciona con una formulacion de formas de dosificacion solidas que comprende una cantidad terapeuticamente efectiva de un antagonista del canal del calcio de tipo dihidropiridina como la lecarnidilipina o sal del mismo.
CR11285A 2007-07-23 2010-02-19 Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihipropiridina y metodo para la prepacion de la misma CR11285A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2007/006517 WO2009012791A1 (en) 2007-07-23 2007-07-23 Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Publications (1)

Publication Number Publication Date
CR11285A true CR11285A (es) 2010-04-27

Family

ID=39223083

Family Applications (1)

Application Number Title Priority Date Filing Date
CR11285A CR11285A (es) 2007-07-23 2010-02-19 Composicion farmaceutica que contiene un antagonista del canal de calcio de tipo dihipropiridina y metodo para la prepacion de la misma

Country Status (20)

Country Link
EP (2) EP2180883B1 (es)
JP (2) JP5769963B2 (es)
KR (2) KR101632079B1 (es)
CN (3) CN101784260A (es)
AU (2) AU2007356942B2 (es)
BR (2) BRPI0721883A2 (es)
CA (2) CA2691752C (es)
CO (1) CO6290639A2 (es)
CR (1) CR11285A (es)
EA (2) EA021645B1 (es)
EC (1) ECSP109984A (es)
ES (2) ES2622495T3 (es)
MA (1) MA31684B1 (es)
MX (2) MX2010000856A (es)
MY (1) MY153857A (es)
NZ (2) NZ582648A (es)
TN (2) TN2010000011A1 (es)
UA (2) UA97161C2 (es)
WO (2) WO2009012791A1 (es)
ZA (2) ZA201000586B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US20100190777A1 (en) 2007-07-17 2010-07-29 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
EP2180883B1 (en) * 2007-07-23 2017-01-11 Pharmathen S.A. Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof
HUE027598T2 (en) 2009-04-03 2016-10-28 Hoffmann La Roche Propane-1-sulfonic acid {3- [5- (4-chlorophenyl) -1H-pyrrolo [2,3-B] pyridine-3-carbonyl] -2,4-difluorophenyl} amide compositions and their uses
US8329724B2 (en) 2009-08-03 2012-12-11 Hoffmann-La Roche Inc. Process for the manufacture of pharmaceutically active compounds
ES2633317T3 (es) 2009-11-06 2017-09-20 Plexxikon, Inc. Compuestos y métodos para la modulación de quinasas, e indicaciones para ello
MA34948B1 (fr) 2011-02-07 2014-03-01 Plexxikon Inc Composes et procedes de modulation de kinase, et leurs indications
TWI558702B (zh) 2011-02-21 2016-11-21 普雷辛肯公司 醫藥活性物質的固態形式
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
CN105050708A (zh) 2012-11-14 2015-11-11 格雷斯公司 含有生物活性材料与无序无机氧化物的组合物
GR1008554B (el) * 2014-06-12 2015-09-03 ΦΑΡΜΑΤΕΝ ΑΝΩΝΥΜΟΣ ΒΙΟΜΗΧΑΝΙΚΗ ΚΑΙ ΕΜΠΟΡΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΙΑΤΡΙΚΩΝ ΚΑΙ ΚΑΛΛΥΝΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ με δ.τ. ΦΑΡΜΑΤΕΝ, Φαρμακευτικο σκευασμα περιεχον εναν αντιμυκητιασικο παραγοντα τριaζολης και μεθοδος για την παρασκευη αυτου
CN104069500A (zh) * 2014-06-20 2014-10-01 湖南天地恒一制药有限公司 一种包含乐卡地平的药物组合物
CN105168165B (zh) * 2015-08-28 2018-06-26 江苏福邦药业有限公司 一种盐酸乐卡地平片及其制备方法
WO2018004379A1 (ru) * 2016-07-01 2018-01-04 Общество С Ограниченной Ответственностью "Гиостин" Средство в виде капсулы для лечения заболеваний суставов
EP3758686B1 (en) 2018-02-26 2024-11-06 R.P. Scherer Technologies, LLC Pharmaceutical dosage form for an emulsion of simethicone and loperamide
SG11202009174WA (en) 2018-03-22 2020-10-29 Komipharm Int Australia Pty Ltd Pharmaceutical composition comprising meta arsenite and method of manufacture
JP2023107429A (ja) * 2022-01-24 2023-08-03 東芝テック株式会社 読取装置
CN114533686B (zh) * 2022-02-15 2023-10-20 湖南普道医药技术有限公司 一种二氢吡啶类药物的口服固体制剂及其制备方法
KR20240040407A (ko) * 2022-09-21 2024-03-28 주식회사 종근당 사쿠비트릴ㆍ발사르탄 칼슘염을 포함하는 약제학적 조성물

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3720757A1 (de) * 1987-06-24 1989-01-05 Bayer Ag Dhp-manteltablette
US5209933A (en) * 1990-01-10 1993-05-11 Syntex (U.S.A.) Inc. Long acting calcium channel blocker composition
GB9025251D0 (en) * 1990-11-20 1991-01-02 Solomon Montague C Nifedipine dosage forms
BR9903490A (pt) * 1998-12-15 2000-09-26 Oscar Gold Processo para a preparação de composições farmacêuticas de liberação programada contendo nimodipine, que permitem a liberação gradual e a manuntenção da ação terapeutica
DE19944803A1 (de) * 1999-09-20 2001-03-29 Bayer Ag Kombination von Dihydropyridinverbindungen und HMG-CoA-Reduktase-Inhibitoren und ihre Verwendung in Arzneimitteln
US20040185097A1 (en) * 2003-01-31 2004-09-23 Glenmark Pharmaceuticals Ltd. Controlled release modifying complex and pharmaceutical compositions thereof
MXPA06006118A (es) * 2003-12-01 2006-08-11 Lifecycle Pharma As Composiciones farmaceuticas que comprenden lercanidipina.
ZA200605290B (en) * 2003-12-01 2007-10-31 Lifecycle Pharma As Pharmaceutical compositions comprising lercanidipine
MX2009002235A (es) * 2006-08-30 2009-03-13 Jagotec Ag Formulaciones de dosis oral, solidas, de liberacion controlada que comprenden nisoldipina.
WO2008068777A2 (en) * 2006-12-06 2008-06-12 Torrent Pharmaceuticals Limited Stable lercanidipine formulation
EP2180883B1 (en) * 2007-07-23 2017-01-11 Pharmathen S.A. Pharmaceutical composition containing dihydropyridine calcium channel antagonist and method for the preparation thereof

Also Published As

Publication number Publication date
CN101784260A (zh) 2010-07-21
TN2010000022A1 (en) 2011-09-26
TN2010000011A1 (en) 2011-09-26
AU2008280106B2 (en) 2014-03-20
AU2008280106A2 (en) 2010-02-25
EP2180883B1 (en) 2017-01-11
ZA201000586B (en) 2011-03-30
MY153857A (en) 2015-03-31
UA97161C2 (ru) 2012-01-10
EA201000220A1 (ru) 2010-08-30
EP2170295B1 (en) 2015-04-22
MX2010000801A (es) 2010-07-05
BRPI0721883A2 (pt) 2014-02-18
ECSP109984A (es) 2010-04-30
AU2007356942A1 (en) 2009-01-29
CO6290639A2 (es) 2011-06-20
WO2009012791A1 (en) 2009-01-29
MX2010000856A (es) 2010-04-30
CA2691752C (en) 2016-01-26
JP2010534211A (ja) 2010-11-04
CN101801347A (zh) 2010-08-11
NZ582690A (en) 2011-12-22
CA2691752A1 (en) 2009-01-29
KR20100045456A (ko) 2010-05-03
ZA201001176B (en) 2010-11-24
AU2008280106B9 (en) 2014-08-07
EP2180883A1 (en) 2010-05-05
CN103976968A (zh) 2014-08-13
WO2009013306A1 (en) 2009-01-29
JP5769963B2 (ja) 2015-08-26
EA021645B1 (ru) 2015-08-31
NZ582648A (en) 2012-06-29
EA019614B1 (ru) 2014-05-30
AU2007356942B2 (en) 2011-12-15
UA99136C2 (ru) 2012-07-25
JP2010534220A (ja) 2010-11-04
BRPI0814666A2 (pt) 2017-05-09
KR101632079B1 (ko) 2016-06-20
ES2537063T3 (es) 2015-06-02
ES2622495T3 (es) 2017-07-06
EP2170295A1 (en) 2010-04-07
KR20100047848A (ko) 2010-05-10
EA201070160A1 (ru) 2010-06-30
AU2008280106A1 (en) 2009-01-29
MA31684B1 (fr) 2010-09-01
KR101512404B1 (ko) 2015-04-21
CA2693233A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
ECSP109984A (es) Composición farmacéutica mejorada que contiene dihidropiridina, antagonista del canal de calcio y el método para su preparación
UA103915C2 (ru) Твердая лекарственная форма, которая содержит линаглиптин и ингибитор sglt2, и ее применение
EA201200551A1 (ru) Фармацевтическая композиция, фармацевтическая дозированная форма, способы их получения и применения для лечения
CR11137A (es) Valvulas prosteticas de corazon
ECSP13012573A (es) 6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3
BR112015022782A2 (pt) composto, composição farmacêutica, combinação, e, uso de um composto
MX2011011486A (es) Composiciones orales que contienen compuestos de poliguandino y metodos de preparacion y uso de las mismas.
BR112012007747A2 (pt) Compostos heterocíclicos úteis como inibidores de pdk1, sua composição farmacêutica e seus usos
GT200800185A (es) Formulaciones para administracion parenteral de compuestos y sus usos
PA8780201A1 (es) Derivados de pirasol sustituidos con heteroaril utiles para tratar trastornos hiperproliferativos y enfermedades asociadas con angiogénesis
UA94942C2 (ru) Фармацевтические композиции с ингибиторами dpp iv
CR10355A (es) Antagonistas de los piridil amida de los canales de calcio de tipo t
EA201101192A1 (ru) Фармацевтическая композиция, включающая производные глюкопиранозилдифенилметана, фармацевтическая дозированная форма, содержащая указанные производные, способ их получения и применения для улучшения гликемического контроля у пациентов
BR112015022096A8 (pt) compostos moduladores de canal de sódio, composição que os compreende e uso dos mesmos
UY32776A (es) Compuestos de imidazopirazinas sustituidas para el tratamiento de enfermedades parasitarias,composiciones farmacéuticas que los contienen y aplicación.
PH12012500870A1 (en) Spiro-oxindole mdm2 antagonists
BR112012013164A2 (pt) composições farmacêuticas para o estímulo de células-tronco
ECSP15007358A (es) Pirrol carboxamidas fluorometilo sustituidas
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
GT201300241A (es) Composicion farmaceutica antihipertensiva
BR122020011180B8 (pt) formulações injetáveis de compostos de tetraciclina
ECSP13012453A (es) 2-oxi-quinolina-3-carboxamidas sustituidas como moduladores KCNQ2/3
MX2019003010A (es) Composición farmacéutica de clozapina de liberación prolongada.
EA201171414A1 (ru) Ингибиторы белков семейства iap
EA201200485A1 (ru) Перорально распадающаяся фармацевтическая лекарственная форма, содержащая арипипразол